世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preimplantation Genetic Diagnostics (PGD) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4751 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、着床前遺伝子診断（PGD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（着床前遺伝子スクリーニング、着床前遺伝子診断）、用途別市場規模（不妊治療クリニック、学術医療センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・着床前遺伝子診断（PGD）の市場動向 ・企業の競争状況、市場シェア ・着床前遺伝子診断（PGD）の種類別市場規模と予測2016-2027（着床前遺伝子スクリーニング、着床前遺伝子診断） ・着床前遺伝子診断（PGD）の用途別市場規模と予測2016-2027（不妊治療クリニック、学術医療センター、その他） ・着床前遺伝子診断（PGD）の北米市場規模2016-2027（アメリカ、カナダ） ・着床前遺伝子診断（PGD）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・着床前遺伝子診断（PGD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・着床前遺伝子診断（PGD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・着床前遺伝子診断（PGD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina, Inc.、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Perkinelmer, Inc.、Cooper Surgical、ABBott Laboratories、Natera, Inc.、Rubicon Genomics、Oxford Gene Technology、Yikon Genomics、Scigene、Beijing Genomics Institute (BGI)、Genea Limited、Hamilton Thorne、FUJIFILM Irvine Scientific、Nidacon International、Vitrolife AB、Merck、INVO Bioscience、IVFtech、Gonagen Medikal、Cook Medical、CellCura） ・結論

Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child.

Market Analysis and Insights: Global Preimplantation Genetic Diagnostics (PGD) Market
The global Preimplantation Genetic Diagnostics (PGD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preimplantation Genetic Diagnostics (PGD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preimplantation Genetic Diagnostics (PGD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preimplantation Genetic Diagnostics (PGD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preimplantation Genetic Diagnostics (PGD) market.

Global Preimplantation Genetic Diagnostics (PGD) Scope and Market Size
Preimplantation Genetic Diagnostics (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Diagnostics (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segment by Application
Fertility Clinics
Academic Medical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Preimplantation Genetic Screening
1.2.3 Preimplantation Genetic Diagnosis
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Fertility Clinics
1.3.3 Academic Medical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2016-2027)
2.2 Preimplantation Genetic Diagnostics (PGD) Growth Trends by Regions
2.2.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Share by Regions (2016-2021)
2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2022-2027)
2.3 Preimplantation Genetic Diagnostics (PGD) Industry Dynamic
2.3.1 Preimplantation Genetic Diagnostics (PGD) Market Trends
2.3.2 Preimplantation Genetic Diagnostics (PGD) Market Drivers
2.3.3 Preimplantation Genetic Diagnostics (PGD) Market Challenges
2.3.4 Preimplantation Genetic Diagnostics (PGD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2016-2021)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2016-2021)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
3.4 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2020
3.5 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2016-2021)
4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2022-2027)

5 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Application (2016-2021)
5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
6.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type
6.2.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
6.2.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
6.2.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application
6.3.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
6.3.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
6.3.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country
6.4.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
6.4.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type
7.2.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
7.2.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
7.2.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application
7.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
7.3.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
7.3.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country
7.4.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
7.4.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
8.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type
8.2.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application
8.3.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region
8.4.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
9.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type
9.2.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
9.2.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
9.2.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
9.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application
9.3.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
9.3.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
9.3.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
9.4 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country
9.4.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
9.4.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
10.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type
10.2.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application
10.3.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country
10.4.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Details
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.1.5 Illumina, Inc. Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Details
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 Perkinelmer, Inc.
11.4.1 Perkinelmer, Inc. Company Details
11.4.2 Perkinelmer, Inc. Business Overview
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.4.5 Perkinelmer, Inc. Recent Development
11.5 Cooper Surgical
11.5.1 Cooper Surgical Company Details
11.5.2 Cooper Surgical Business Overview
11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction
11.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.5.5 Cooper Surgical Recent Development
11.6 ABBott Laboratories
11.6.1 ABBott Laboratories Company Details
11.6.2 ABBott Laboratories Business Overview
11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction
11.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.6.5 ABBott Laboratories Recent Development
11.7 Natera, Inc.
11.7.1 Natera, Inc. Company Details
11.7.2 Natera, Inc. Business Overview
11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.7.5 Natera, Inc. Recent Development
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Details
11.8.2 Rubicon Genomics Business Overview
11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
11.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.8.5 Rubicon Genomics Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Details
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Details
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.10.5 Yikon Genomics Recent Development
11.11 Scigene
11.11.1 Scigene Company Details
11.11.2 Scigene Business Overview
11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction
11.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.11.5 Scigene Recent Development
11.12 Beijing Genomics Institute (BGI)
11.12.1 Beijing Genomics Institute (BGI) Company Details
11.12.2 Beijing Genomics Institute (BGI) Business Overview
11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction
11.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.12.5 Beijing Genomics Institute (BGI) Recent Development
11.13 Genea Limited
11.13.1 Genea Limited Company Details
11.13.2 Genea Limited Business Overview
11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction
11.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.13.5 Genea Limited Recent Development
11.14 Hamilton Thorne
11.14.1 Hamilton Thorne Company Details
11.14.2 Hamilton Thorne Business Overview
11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction
11.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.14.5 Hamilton Thorne Recent Development
11.15 FUJIFILM Irvine Scientific
11.15.1 FUJIFILM Irvine Scientific Company Details
11.15.2 FUJIFILM Irvine Scientific Business Overview
11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction
11.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.15.5 FUJIFILM Irvine Scientific Recent Development
11.16 Nidacon International
11.16.1 Nidacon International Company Details
11.16.2 Nidacon International Business Overview
11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction
11.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.16.5 Nidacon International Recent Development
11.17 Vitrolife AB
11.17.1 Vitrolife AB Company Details
11.17.2 Vitrolife AB Business Overview
11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction
11.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.17.5 Vitrolife AB Recent Development
11.18 Merck
11.18.1 Merck Company Details
11.18.2 Merck Business Overview
11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction
11.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.18.5 Merck Recent Development
11.18 INVO Bioscience
.1 INVO Bioscience Company Details
.2 INVO Bioscience Business Overview
.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction
.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
.5 INVO Bioscience Recent Development
11.20 IVFtech
11.20.1 IVFtech Company Details
11.20.2 IVFtech Business Overview
11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction
11.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.20.5 IVFtech Recent Development
11.21 Gonagen Medikal
11.21.1 Gonagen Medikal Company Details
11.21.2 Gonagen Medikal Business Overview
11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction
11.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.21.5 Gonagen Medikal Recent Development
11.22 Cook Medical
11.22.1 Cook Medical Company Details
11.22.2 Cook Medical Business Overview
11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction
11.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.22.5 Cook Medical Recent Development
11.23 CellCura
11.23.1 CellCura Company Details
11.23.2 CellCura Business Overview
11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction
11.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
11.23.5 CellCura Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Preimplantation Genetic Screening
Table 3. Key Players of Preimplantation Genetic Diagnosis
Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2016-2021)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2022-2027)
Table 10. Preimplantation Genetic Diagnostics (PGD) Market Trends
Table 11. Preimplantation Genetic Diagnostics (PGD) Market Drivers
Table 12. Preimplantation Genetic Diagnostics (PGD) Market Challenges
Table 13. Preimplantation Genetic Diagnostics (PGD) Market Restraints
Table 14. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2016-2021)
Table 16. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2020)
Table 17. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
Table 21. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2016-2021)
Table 25. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2016-2021)
Table 29. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Illumina, Inc. Company Details
Table 62. Illumina, Inc. Business Overview
Table 63. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 64. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 65. Illumina, Inc. Recent Development
Table 66. Thermo Fisher Scientific Inc. Company Details
Table 67. Thermo Fisher Scientific Inc. Business Overview
Table 68. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 69. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Inc. Recent Development
Table 71. Agilent Technologies, Inc. Company Details
Table 72. Agilent Technologies, Inc. Business Overview
Table 73. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 74. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies, Inc. Recent Development
Table 76. Perkinelmer, Inc. Company Details
Table 77. Perkinelmer, Inc. Business Overview
Table 78. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 79. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 80. Perkinelmer, Inc. Recent Development
Table 81. Cooper Surgical Company Details
Table 82. Cooper Surgical Business Overview
Table 83. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product
Table 84. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 85. Cooper Surgical Recent Development
Table 86. ABBott Laboratories Company Details
Table 87. ABBott Laboratories Business Overview
Table 88. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product
Table 89. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 90. ABBott Laboratories Recent Development
Table 91. Natera, Inc. Company Details
Table 92. Natera, Inc. Business Overview
Table 93. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 94. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 95. Natera, Inc. Recent Development
Table 96. Rubicon Genomics Company Details
Table 97. Rubicon Genomics Business Overview
Table 98. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 99. Rubicon Genomics Recent Development
Table 100. Oxford Gene Technology Company Details
Table 101. Oxford Gene Technology Business Overview
Table 102. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product
Table 103. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 104. Oxford Gene Technology Recent Development
Table 105. Yikon Genomics Company Details
Table 106. Yikon Genomics Business Overview
Table 107. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product
Table 108. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 109. Yikon Genomics Recent Development
Table 110. Scigene Company Details
Table 111. Scigene Business Overview
Table 112. Scigene Preimplantation Genetic Diagnostics (PGD) Product
Table 113. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 114. Scigene Recent Development
Table 115. Beijing Genomics Institute (BGI) Company Details
Table 116. Beijing Genomics Institute (BGI) Business Overview
Table 117. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product
Table 118. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 119. Beijing Genomics Institute (BGI) Recent Development
Table 120. Genea Limited Company Details
Table 121. Genea Limited Business Overview
Table 122. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product
Table 123. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 124. Genea Limited Recent Development
Table 125. Hamilton Thorne Company Details
Table 126. Hamilton Thorne Business Overview
Table 127. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product
Table 128. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 129. Hamilton Thorne Recent Development
Table 130. FUJIFILM Irvine Scientific Company Details
Table 131. FUJIFILM Irvine Scientific Business Overview
Table 132. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product
Table 133. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 134. FUJIFILM Irvine Scientific Recent Development
Table 135. Nidacon International Company Details
Table 136. Nidacon International Business Overview
Table 137. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product
Table 138. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 139. Nidacon International Recent Development
Table 140. Vitrolife AB Company Details
Table 141. Vitrolife AB Business Overview
Table 142. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product
Table 143. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 144. Vitrolife AB Recent Development
Table 145. Merck Company Details
Table 146. Merck Business Overview
Table 147. Merck Preimplantation Genetic Diagnostics (PGD) Product
Table 148. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 149. Merck Recent Development
Table 150. INVO Bioscience Company Details
Table 151. INVO Bioscience Business Overview
Table 152. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product
Table 153. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 154. INVO Bioscience Recent Development
Table 155. IVFtech Company Details
Table 156. IVFtech Business Overview
Table 157. IVFtech Preimplantation Genetic Diagnostics (PGD) Product
Table 158. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 159. IVFtech Recent Development
Table 160. Gonagen Medikal Company Details
Table 161. Gonagen Medikal Business Overview
Table 162. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product
Table 163. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 164. Gonagen Medikal Recent Development
Table 165. Cook Medical Company Details
Table 166. Cook Medical Business Overview
Table 167. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product
Table 168. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 169. Cook Medical Recent Development
Table 170. CellCura Company Details
Table 171. CellCura Business Overview
Table 172. CellCura Preimplantation Genetic Diagnostics (PGD) Product
Table 173. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
Table 174. CellCura Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2020 VS 2027
Figure 2. Preimplantation Genetic Screening Features
Figure 3. Preimplantation Genetic Diagnosis Features
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2027
Figure 5. Fertility Clinics Case Studies
Figure 6. Academic Medical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions: 2020 VS 2027
Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2022-2027)
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2020
Figure 14. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2020
Figure 16. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2016-2021)
Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2022-2027)
Figure 18. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
Figure 20. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
Figure 21. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
Figure 22. United States Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
Figure 26. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
Figure 27. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
Figure 28. Germany Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2016-2027)
Figure 38. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
Figure 46. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
Figure 47. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
Figure 48. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
Figure 54. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 59. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 60. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 61. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 62. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 63. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 64. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 65. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 66. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 67. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 68. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 69. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 70. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 71. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 72. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 73. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 75. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 76. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 77. Gonagen Medikal Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 78. Cook Medical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 79. CellCura Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---